autonomic drugs (brief) Flashcards
Bethanechol
cholinomimetic
Use: Non obstructed bowel constipation and urinary retention
MOA: cholinomimetic (non selective nicotinic and muscarinic). Increase secretion/motor activity gut
Pilocarpine
Cholinomimetic
Use: increase salivation, open and closed angle glaucoma
MOA: contract ciliary body (accommodation, open angle G), contract sphincter pupillae (miosis, closed angle G)
Methacholine
Cholinomimetic, inhaled
Use: Trigger asthma in asthma testing
MOA: contract bronchial smooth muscle
Carbachol
Cholinomimetic
Use: open angle glaucoma
MOA: Pupil constriction (muscarinic and nicotinic agonist).
Varenicline
Cholinomimetic
Use: cigarette cessation
MOA: partial agonist nicotinic
Neostigmine
Indirect cholinomimetic
Use: Myasthenia gravis (uncommon), postop neurogenic ileus/urinary retention, NMJ block reversal
MOA: Quaternary Ach esterase inhibitor
Pyridostigmine
Indirect cholinomimetic
Use: Myasthenia gravis (long acting)
MOA: quaternary ach esterase inhibitor
Edrophonium
Indirect cholinomimetic
Use: Myasthenia gravis dx, tensilon test
MOA: quaternary ach esterase inhibitor
Physostigmine
Indirect cholinomimetic
Use: Atropine toxicity
MOA: tertiary ach esterase inhibitor (goes into CNS)
cholinesterase inhibitor SE/poisoning
DUMBBELSS
Diarrhea, urination, miosis, bronchospasm, bradycardia, excitation (skeletal muscle/CNS), lacrimation, sweating, salivation
organophosphate (thiosulfates)
MOA: irreversible cholinesterase inhibitors used in insecticides
organophosphate poisoning treatment
Pralidoxime: hydrolyze covalent bond between cholinesterase/organophosphate. Not in CNS
Atropine: Reverse peripheral and CNS effects, can’t reverse NMJ blockade
Galantamine
Indirect cholinomimetic
Use: cognitive dysfx alzheimers
MOA: cholinesterase inhibitor that penetrates CNS. Increase ACh
Donepezil
Indirect cholinomimetic
Use: cognitive dysfx alzheimers
MOA: cholinesterase inhibitor that penetrates CNS. Increase ACh
Rivastigmine
Indirect cholinomimetic
Use: cognitive dysfx alzheimers
MOA: cholinesterase inhibitor that penetrates CNS. Increase ACh
Muscarinic antagonists MOA and SE overview
MOA: eye: increase pupil dilation, cycloplegia Airway: decrease secretions Stomach: decrease acid secretion Gut: decrease motility Bladder: Decrease urgency in cystitis
Heart: increase HR (SA node) reverse AV nodal HB
BLOCK DUMBBeLSS
SE: Increased temp (decreased sweating) Dry flushed skin, cycloplegia, disorientation, closed angle glaucoma
Hot as a hare, dry as a cracker, blind as a bat, high pressure as a kettle, mad as a hatter
Cycloplegia
paralysis of ciliary muscles in eye resulting in loss of accommodaiton
Atropine
Muscarinic antagonist
Use: eye: mydriasis, bradyarrhythmia, AV nodal block (IV)
Ipratropium
Muscarinic antagonist
Use: Inhaled treatment COPD
Tiotropium
Muscarinic antagonist
Use: inhalational drug COPD (long half life)
Oxybutynin
Muscarinic antagonist
Use: Incontinence, overactive bladder
Tolterodine
Muscarinic antagonist
Use: urinary incontinence
Scopolamine
Muscarinic antagonist
Use: motion sickness
Benztropine
Muscarinic antagonist
Use: tremor and rigidity parkinson’s, EPS, no help w/ bradykinesia
Trihexyphenidyl
Muscarinic antagonist
Use: tremor and rigidity parkinson’s, EPS, no help w/ bradykinesia
Norepi
Use: Hypotension, septic shock
MOA: a1>a2>b1 agonist
arteriolar vasoconstriction, increased contractility, increased SBP, DBP, MAP.
SE: reflex brady, wins out over b1 agonism. Widened pulse pressure (whenever b1 hit).
Brimonidine
Use: open angle glaucoma
MOA: a2 agonist. Decrease aqueous humor production
Phenylephrine
Use: Hypotension, mydriatic for ocular procedures, rhinitis
MOA: a1>a2
Increase SBP, DBP, MAP
SE: reflex brady (doesn’t occur w/ diabetic neuropathy)
Epi
Use: anaphylaxis, asthma, open angle glaucoma, cardiac resuscitation, shok
MOA: all b & a. b predominate at low dose, a at high doses.
Norepi MAP tracing
BP: SBP, MAP, DBP increase. widened PP
HR: reflex brady
PR: Increased, unopposed a1